| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 5'-3' DNA helicase activity | 4.69e-05 | 11 | 134 | 3 | GO:0043139 | |
| GeneOntologyMolecularFunction | triplex DNA binding | 2.66e-04 | 4 | 134 | 2 | GO:0045142 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CCNL2 DNHD1 ATG16L1 CFAP73 PLA2G3 HAUS5 KIAA1614 GOLGA8N CEP350 CFAP54 KIF15 FAM107A CEP250 PDE4DIP CCDC78 CFAP45 MAP3K11 CCDC120 CFAP74 CTNNB1 ARHGEF2 CFAP44 GOLGA8O ODAD3 UVRAG BBOF1 | 4.60e-09 | 1058 | 135 | 26 | GO:0007017 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CCNL2 CFAP73 PLA2G3 HAUS5 KIAA1614 GOLGA8N CEP350 KIF15 FAM107A CEP250 PDE4DIP CCDC78 CCDC120 CFAP74 CTNNB1 ARHGEF2 CFAP44 GOLGA8O ODAD3 UVRAG BBOF1 | 9.27e-09 | 720 | 135 | 21 | GO:0000226 |
| GeneOntologyBiologicalProcess | microtubule organizing center organization | CCNL2 HAUS5 KIAA1614 GOLGA8N KIF15 CEP250 PDE4DIP CCDC78 CTNNB1 GOLGA8O UVRAG | 2.72e-08 | 179 | 135 | 11 | GO:0031023 |
| GeneOntologyBiologicalProcess | centrosome cycle | CCNL2 HAUS5 KIAA1614 GOLGA8N KIF15 CEP250 PDE4DIP CTNNB1 GOLGA8O UVRAG | 1.29e-07 | 164 | 135 | 10 | GO:0007098 |
| GeneOntologyBiologicalProcess | organelle assembly | DNHD1 ATG16L1 ERICH3 CFAP73 NOP53 PLA2G3 HAUS5 RNF213 ABT1 ACTN2 TP53INP2 MKS1 GOLGA8N CEP350 CFAP54 KIF15 CEP250 CCDC78 CFAP74 ARHGEF2 CFAP44 GOLGA8O ODAD3 BBOF1 | 3.39e-07 | 1138 | 135 | 24 | GO:0070925 |
| GeneOntologyBiologicalProcess | cell cycle process | MYC CCNL2 UBR2 AICDA NOP53 STRA8 HAUS5 KIAA1614 GOLGA8N DDX11 SPC24 TLK1 KIF15 FAM107A ANAPC1 GLI1 CEP250 PDE4DIP CTDP1 MAP3K11 CTNNB1 ARHGEF2 GOLGA8O UVRAG DDX11L8 | 6.43e-06 | 1441 | 135 | 25 | GO:0022402 |
| GeneOntologyBiologicalProcess | cilium organization | DNHD1 ERICH3 CFAP73 PLA2G3 MKS1 CEP350 CFAP54 CEP250 CFAP74 CFAP44 TSGA10IP ODAD3 BBOF1 | 1.52e-05 | 476 | 135 | 13 | GO:0044782 |
| GeneOntologyBiologicalProcess | motile cilium assembly | 2.45e-05 | 88 | 135 | 6 | GO:0044458 | |
| GeneOntologyBiologicalProcess | sperm flagellum assembly | 3.26e-05 | 56 | 135 | 5 | GO:0120316 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | DNHD1 ERICH3 CFAP73 PLA2G3 ACTN2 MKS1 CEP350 CFAP54 CEP250 TENM1 PALM CFAP74 CFAP44 ODAD3 BBOF1 | 3.38e-05 | 670 | 135 | 15 | GO:0120031 |
| GeneOntologyBiologicalProcess | cilium assembly | DNHD1 ERICH3 CFAP73 PLA2G3 MKS1 CEP350 CFAP54 CEP250 CFAP74 CFAP44 ODAD3 BBOF1 | 3.62e-05 | 444 | 135 | 12 | GO:0060271 |
| GeneOntologyBiologicalProcess | cell projection assembly | DNHD1 ERICH3 CFAP73 PLA2G3 ACTN2 MKS1 CEP350 CFAP54 CEP250 TENM1 PALM CFAP74 CFAP44 ODAD3 BBOF1 | 4.35e-05 | 685 | 135 | 15 | GO:0030031 |
| GeneOntologyBiologicalProcess | asymmetric cell division | 6.99e-05 | 34 | 135 | 4 | GO:0008356 | |
| GeneOntologyBiologicalProcess | axoneme assembly | 8.20e-05 | 109 | 135 | 6 | GO:0035082 | |
| GeneOntologyBiologicalProcess | regulation of centriole-centriole cohesion | 1.27e-04 | 3 | 135 | 2 | GO:0030997 | |
| GeneOntologyBiologicalProcess | flagellated sperm motility | 2.27e-04 | 186 | 135 | 7 | GO:0030317 | |
| GeneOntologyBiologicalProcess | sperm motility | 2.84e-04 | 193 | 135 | 7 | GO:0097722 | |
| GeneOntologyBiologicalProcess | cerebrospinal fluid circulation | 2.88e-04 | 20 | 135 | 3 | GO:0090660 | |
| GeneOntologyBiologicalProcess | cilium movement | 3.28e-04 | 261 | 135 | 8 | GO:0003341 | |
| GeneOntologyBiologicalProcess | germ cell development | MYCN DNHD1 CFAP73 STRA8 PLA2G3 RNF17 CFAP54 GLI1 CTNNB1 CFAP44 BBOF1 | 3.36e-04 | 482 | 135 | 11 | GO:0007281 |
| GeneOntologyBiologicalProcess | spermatid development | 3.36e-04 | 262 | 135 | 8 | GO:0007286 | |
| GeneOntologyCellularComponent | microtubule organizing center | FAM184A PLA2G3 HAUS5 MKS1 DDX11 CEP350 KIF15 CEP250 PDE4DIP CCDC78 CTDP1 MAP3K11 CCDC120 CTNNB1 TSGA10IP NEURL4 ODAD3 UVRAG DDX11L8 SMTNL2 BBOF1 | 5.83e-07 | 919 | 137 | 21 | GO:0005815 |
| GeneOntologyCellularComponent | axoneme | DNHD1 ATG16L1 CFAP73 SPTBN5 CFAP54 GLI1 CFAP45 CFAP74 ODAD3 BBOF1 | 1.12e-06 | 207 | 137 | 10 | GO:0005930 |
| GeneOntologyCellularComponent | ciliary plasm | DNHD1 ATG16L1 CFAP73 SPTBN5 CFAP54 GLI1 CFAP45 CFAP74 ODAD3 BBOF1 | 1.17e-06 | 208 | 137 | 10 | GO:0097014 |
| GeneOntologyCellularComponent | centriole | 1.81e-05 | 172 | 137 | 8 | GO:0005814 | |
| GeneOntologyCellularComponent | cytoplasmic region | DNHD1 ATG16L1 CFAP73 SPTBN5 CFAP54 GLI1 CFAP45 CFAP74 CTNNB1 ODAD3 BBOF1 | 2.60e-05 | 360 | 137 | 11 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | DNHD1 ATG16L1 CFAP73 SPTBN5 CFAP54 GLI1 CFAP45 CFAP74 ODAD3 BBOF1 | 4.68e-05 | 317 | 137 | 10 | GO:0032838 |
| GeneOntologyCellularComponent | spindle pole | 6.33e-05 | 205 | 137 | 8 | GO:0000922 | |
| GeneOntologyCellularComponent | spindle | MYC HAUS5 GOLGA8N DDX11 CEP350 KIF15 CEP250 CTDP1 CTNNB1 ARHGEF2 GOLGA8O DDX11L8 | 6.50e-05 | 471 | 137 | 12 | GO:0005819 |
| GeneOntologyCellularComponent | cis-Golgi network | 2.42e-04 | 85 | 137 | 5 | GO:0005801 | |
| GeneOntologyCellularComponent | Golgi cisterna | 2.67e-04 | 135 | 137 | 6 | GO:0031985 | |
| GeneOntologyCellularComponent | cilium | DNHD1 ATG16L1 ERICH3 CFAP73 MKS1 SPTBN5 CFAP54 GLI1 CEP250 CFAP45 CCDC120 CFAP74 CFAP44 TSGA10IP ODAD3 BBOF1 | 2.69e-04 | 898 | 137 | 16 | GO:0005929 |
| GeneOntologyCellularComponent | apicolateral plasma membrane | 8.00e-04 | 28 | 137 | 3 | GO:0016327 | |
| GeneOntologyCellularComponent | Golgi stack | 9.32e-04 | 171 | 137 | 6 | GO:0005795 | |
| GeneOntologyCellularComponent | Golgi cis cisterna | 1.30e-03 | 33 | 137 | 3 | GO:0000137 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.42e-03 | 74 | 137 | 4 | GO:0043198 | |
| GeneOntologyCellularComponent | centrosome | FAM184A HAUS5 MKS1 DDX11 CEP350 KIF15 CEP250 PDE4DIP CTDP1 MAP3K11 CTNNB1 UVRAG DDX11L8 | 1.67e-03 | 770 | 137 | 13 | GO:0005813 |
| GeneOntologyCellularComponent | Ctf18 RFC-like complex | 1.85e-03 | 10 | 137 | 2 | GO:0031390 | |
| MousePheno | abnormal motile cilium physiology | 3.88e-05 | 51 | 105 | 5 | MP:0013209 | |
| MousePheno | domed cranium | 4.21e-05 | 85 | 105 | 6 | MP:0000440 | |
| MousePheno | abnormal cilium physiology | 4.68e-05 | 53 | 105 | 5 | MP:0013208 | |
| Domain | CH | 6.52e-06 | 65 | 132 | 6 | SM00033 | |
| Domain | CH | 1.01e-05 | 70 | 132 | 6 | PF00307 | |
| Domain | - | 1.09e-05 | 71 | 132 | 6 | 1.10.418.10 | |
| Domain | CH | 1.28e-05 | 73 | 132 | 6 | PS50021 | |
| Domain | CH-domain | 1.50e-05 | 75 | 132 | 6 | IPR001715 | |
| Domain | Gonadal | 4.96e-05 | 2 | 132 | 2 | IPR010849 | |
| Domain | DGCR6 | 4.96e-05 | 2 | 132 | 2 | PF07324 | |
| Domain | DUF4515 | 1.48e-04 | 3 | 132 | 2 | IPR032777 | |
| Domain | DUF4515 | 1.48e-04 | 3 | 132 | 2 | PF14988 | |
| Domain | Myc_N | 2.95e-04 | 4 | 132 | 2 | PF01056 | |
| Domain | Tscrpt_reg_Myc_N | 2.95e-04 | 4 | 132 | 2 | IPR012682 | |
| Domain | Tscrpt_reg_Myc | 2.95e-04 | 4 | 132 | 2 | IPR002418 | |
| Domain | Spectrin | 5.51e-04 | 23 | 132 | 3 | PF00435 | |
| Domain | ACTININ_2 | 5.51e-04 | 23 | 132 | 3 | PS00020 | |
| Domain | ACTININ_1 | 5.51e-04 | 23 | 132 | 3 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 5.51e-04 | 23 | 132 | 3 | IPR001589 | |
| Domain | EFhand_Ca_insen | 7.30e-04 | 6 | 132 | 2 | PF08726 | |
| Domain | EF-hand_Ca_insen | 7.30e-04 | 6 | 132 | 2 | IPR014837 | |
| Domain | Spectrin_repeat | 1.10e-03 | 29 | 132 | 3 | IPR002017 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 1.79e-05 | 9 | 86 | 3 | MM1366 | |
| Pathway | BIOCARTA_CELL2CELL_PATHWAY | 4.63e-05 | 12 | 86 | 3 | M12851 | |
| Pubmed | Sox9 plays multiple roles in the lung epithelium during branching morphogenesis. | 5.25e-08 | 50 | 140 | 6 | 24191021 | |
| Pubmed | TP53, β-Catenin and c-myc/N-myc status in embryonal tumours with ependymoblastic rosettes. | 2.55e-07 | 4 | 140 | 3 | 21073496 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | EDC4 TNFRSF21 CCDC142 TLK1 ARAP3 BRD2 KCNH2 GLI1 NBEAL2 CTDP1 MAP3K11 PALM SH3BP5L ARHGEF2 GNAZ SYVN1 DHX34 UVRAG | 5.25e-07 | 1105 | 140 | 18 | 35748872 |
| Pubmed | Shh controls epithelial proliferation via independent pathways that converge on N-Myc. | 1.43e-06 | 21 | 140 | 4 | 16054035 | |
| Pubmed | Ror2 enhances polarity and directional migration of primordial germ cells. | 1.43e-06 | 21 | 140 | 4 | 22216013 | |
| Pubmed | LRCH2 TSC1 EDC4 SIPA1 TRIP11 GOLGA8N EPM2AIP1 KIF15 ANAPC1 PDE4DIP LRRC7 CTNNB1 ARHGEF2 GOLGA8O UNC79 NEURL4 | 1.83e-06 | 963 | 140 | 16 | 28671696 | |
| Pubmed | 2.21e-06 | 7 | 140 | 3 | 12441288 | ||
| Pubmed | Germinal Center Selection and Affinity Maturation Require Dynamic Regulation of mTORC1 Kinase. | 3.52e-06 | 8 | 140 | 3 | 28636954 | |
| Pubmed | 3.52e-06 | 8 | 140 | 3 | 24923387 | ||
| Pubmed | LRCH2 TSC1 ACTN2 ACTN3 EDC4 SIPA1 TRIP11 LRCH3 HSPA12A THBS4 UPF2 PDE4DIP MAST1 PALM LRRC7 CTNNB1 ARHGEF2 GNAZ RPL4 | 5.03e-06 | 1431 | 140 | 19 | 37142655 | |
| Pubmed | Polycystic kidneys caused by sustained expression of Cux1 isoform p75. | 5.27e-06 | 9 | 140 | 3 | 18356167 | |
| Pubmed | UBR2 LRCH2 TSC1 EPM2AIP1 RHOBTB2 PDE4DIP MAST1 LRRC7 SH3BP5L SYVN1 | 6.41e-06 | 407 | 140 | 10 | 12693553 | |
| Pubmed | 7.50e-06 | 10 | 140 | 3 | 26290144 | ||
| Pubmed | PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development. | 7.50e-06 | 10 | 140 | 3 | 29046336 | |
| Pubmed | 1.03e-05 | 11 | 140 | 3 | 16396903 | ||
| Pubmed | Palmitoylation regulates epidermal homeostasis and hair follicle differentiation. | 1.06e-05 | 34 | 140 | 4 | 19956733 | |
| Pubmed | A transition zone complex regulates mammalian ciliogenesis and ciliary membrane composition. | 1.50e-05 | 37 | 140 | 4 | 21725307 | |
| Pubmed | TRIM6 interacts with Myc and maintains the pluripotency of mouse embryonic stem cells. | 1.61e-05 | 2 | 140 | 2 | 22328504 | |
| Pubmed | Low-level copy number changes of MYC genes have a prognostic impact in medulloblastoma. | 1.61e-05 | 2 | 140 | 2 | 20607354 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 34630086 | ||
| Pubmed | C-Myc participates in β-catenin-mediated drug resistance in A549/DDP lung adenocarcinoma cells. | 1.61e-05 | 2 | 140 | 2 | 25131138 | |
| Pubmed | Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal. | 1.61e-05 | 2 | 140 | 2 | 28007786 | |
| Pubmed | myc maintains embryonic stem cell pluripotency and self-renewal. | 1.61e-05 | 2 | 140 | 2 | 20537458 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32334373 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18308950 | ||
| Pubmed | Wnt signalling is a bi-directional vulnerability of cancer cells. | 1.61e-05 | 2 | 140 | 2 | 27531891 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28260015 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18851746 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22090452 | ||
| Pubmed | Myc represses primitive endoderm differentiation in pluripotent stem cells. | 1.61e-05 | 2 | 140 | 2 | 20804970 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22184065 | ||
| Pubmed | Hematopoietic stem cell function and survival depend on c-Myc and N-Myc activity. | 1.61e-05 | 2 | 140 | 2 | 19041778 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19150855 | ||
| Pubmed | Myc is required for β-catenin-mediated mammary stem cell amplification and tumorigenesis. | 1.61e-05 | 2 | 140 | 2 | 24171719 | |
| Pubmed | Fibroblast-Specific β-Catenin Signaling Dictates the Outcome of AKI. | 1.61e-05 | 2 | 140 | 2 | 29343518 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22253474 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19696509 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 35645127 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 2120050 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22976998 | ||
| Pubmed | ZNF367-induced transcriptional activation of KIF15 accelerates the progression of breast cancer. | 1.61e-05 | 2 | 140 | 2 | 32549756 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23108410 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 25266063 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 23901000 | ||
| Pubmed | GABA(B) receptor subunit 1 binds to proteins affected in 22q11 deletion syndrome. | 1.61e-05 | 2 | 140 | 2 | 20036641 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15972952 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 20143187 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15126105 | ||
| Pubmed | GSK3 suppression upregulates β-catenin and c-Myc to abrogate KRas-dependent tumors. | 1.61e-05 | 2 | 140 | 2 | 30514931 | |
| Pubmed | Myc Depletion Induces a Pluripotent Dormant State Mimicking Diapause. | 1.61e-05 | 2 | 140 | 2 | 26871632 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9605865 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 17251349 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32451822 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1339456 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1459449 | ||
| Pubmed | Metabolic maintenance of cell asymmetry following division in activated T lymphocytes. | 1.61e-05 | 2 | 140 | 2 | 27064903 | |
| Pubmed | AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. | 1.61e-05 | 2 | 140 | 2 | 19070574 | |
| Pubmed | Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt lymphoma. | 1.61e-05 | 2 | 140 | 2 | 23525267 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 32071436 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 9675099 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28049551 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18242516 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 33336736 | ||
| Pubmed | Role of activation-induced cytidine deaminase in the progression of follicular lymphoma. | 1.61e-05 | 2 | 140 | 2 | 22168746 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 22832905 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 30134066 | ||
| Pubmed | Expression of N-myc in teratocarcinoma stem cells and mouse embryos. | 1.61e-05 | 2 | 140 | 2 | 3840574 | |
| Pubmed | Densin and beta-catenin form a complex and co-localize in cultured podocyte cell junctions. | 1.61e-05 | 2 | 140 | 2 | 17581699 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 28533663 | ||
| Pubmed | MYC and MYCN amplification can be reliably assessed by aCGH in medulloblastoma. | 1.61e-05 | 2 | 140 | 2 | 23578955 | |
| Pubmed | A role for AID in chromosome translocations between c-myc and the IgH variable region. | 1.61e-05 | 2 | 140 | 2 | 17724134 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 16724113 | ||
| Pubmed | Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin. | 1.61e-05 | 2 | 140 | 2 | 27619912 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 19329935 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 15821931 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24190252 | ||
| Pubmed | β-Catenin-Gli1 interaction regulates proliferation and tumor growth in medulloblastoma. | 1.61e-05 | 2 | 140 | 2 | 25645196 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 1644290 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 18678733 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 26996564 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 11157784 | ||
| Pubmed | Expression of C-myc and β-catenin and their correlation in triple negative breast cancer. | 1.61e-05 | 2 | 140 | 2 | 28889723 | |
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 7529553 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 21135131 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 2031852 | ||
| Pubmed | 1.61e-05 | 2 | 140 | 2 | 24608896 | ||
| Pubmed | Wnt/beta-catenin signaling is required for development of the exocrine pancreas. | 1.77e-05 | 13 | 140 | 3 | 17222338 | |
| Pubmed | Activation of Hedgehog signaling by loss of GNAS causes heterotopic ossification. | 2.25e-05 | 14 | 140 | 3 | 24076664 | |
| Pubmed | Golgi disruption and early embryonic lethality in mice lacking USO1. | 2.80e-05 | 15 | 140 | 3 | 23185636 | |
| Pubmed | 3.44e-05 | 16 | 140 | 3 | 17631878 | ||
| Pubmed | Cep55 regulation of PI3K/Akt signaling is required for neocortical development and ciliogenesis. | 4.17e-05 | 17 | 140 | 3 | 34710087 | |
| Pubmed | [Effect of Meisoindigo on Wnt signal pathway in K562 and HL-60 cells]. | 4.81e-05 | 3 | 140 | 2 | 20561405 | |
| Pubmed | Wnt signaling stimulates transcriptional outcome of the Hedgehog pathway by stabilizing GLI1 mRNA. | 4.81e-05 | 3 | 140 | 2 | 19887615 | |
| Pubmed | The expressions of Wnt/β-catenin pathway-related components in brainstem gliomas. | 4.81e-05 | 3 | 140 | 2 | 23603171 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 14624490 | ||
| Pubmed | Phosphatidylinositol 3-kinase δ blockade increases genomic instability in B cells. | 4.81e-05 | 3 | 140 | 2 | 28199309 | |
| Pubmed | Isolation and characterization of Nmi, a novel partner of Myc proteins. | 4.81e-05 | 3 | 140 | 2 | 8668343 | |
| Pubmed | Tuberous sclerosis complex is required for tumor maintenance in MYC-driven Burkitt's lymphoma. | 4.81e-05 | 3 | 140 | 2 | 30237309 | |
| Pubmed | β-catenin induces expression of prohibitin gene in acute leukemic cells. | 4.81e-05 | 3 | 140 | 2 | 28440457 | |
| Pubmed | 4.81e-05 | 3 | 140 | 2 | 32089544 | ||
| Interaction | CCDC136 interactions | CCDC185 NOP53 ABT1 MKS1 FAM50B FAM107A CCDC120 TSGA10IP NEURL4 ODAD3 | 2.26e-07 | 169 | 136 | 10 | int:CCDC136 |
| Interaction | SELENOH interactions | 4.76e-06 | 37 | 136 | 5 | int:SELENOH | |
| Interaction | MRPS18C interactions | 6.34e-06 | 192 | 136 | 9 | int:MRPS18C | |
| Interaction | FYTTD1 interactions | 9.98e-06 | 154 | 136 | 8 | int:FYTTD1 | |
| Interaction | RPP25L interactions | 1.07e-05 | 74 | 136 | 6 | int:RPP25L | |
| Interaction | MRPS9 interactions | MYC MYCN ATG16L1 NOP53 ZNF689 ABT1 ZNF467 TEFM MTRF1 CEP250 MAST1 RPL4 | 1.11e-05 | 382 | 136 | 12 | int:MRPS9 |
| Interaction | MRPS33 interactions | 1.88e-05 | 168 | 136 | 8 | int:MRPS33 | |
| Interaction | SYNPO2 interactions | 3.09e-05 | 27 | 136 | 4 | int:SYNPO2 | |
| Interaction | TFIP11 interactions | MYC MYCN DGCR6 STRA8 TSC1 EPM2AIP1 FAM50B PDE4DIP CCDC120 GCC1 TSGA10IP ODAD3 | 3.33e-05 | 427 | 136 | 12 | int:TFIP11 |
| Interaction | CDR2 interactions | 4.05e-05 | 137 | 136 | 7 | int:CDR2 | |
| Interaction | LZTS2 interactions | ATG16L1 FAM184A DGCR6 TSC1 ABT1 SIPA1 DGCR6L FAM50B FAM107A CEP250 MAST1 GCC1 CTNNB1 | 4.44e-05 | 512 | 136 | 13 | int:LZTS2 |
| Interaction | MRPS35 interactions | 4.55e-05 | 307 | 136 | 10 | int:MRPS35 | |
| Interaction | ANKIB1 interactions | 4.77e-05 | 11 | 136 | 3 | int:ANKIB1 | |
| Interaction | BECN2 interactions | 4.77e-05 | 11 | 136 | 3 | int:BECN2 | |
| Interaction | PPP1R18 interactions | 4.87e-05 | 141 | 136 | 7 | int:PPP1R18 | |
| Interaction | KRT23 interactions | 5.42e-05 | 31 | 136 | 4 | int:KRT23 | |
| Interaction | VPS52 interactions | 5.45e-05 | 195 | 136 | 8 | int:VPS52 | |
| Interaction | CEP170 interactions | MYC MYCN ATG16L1 BRD2 CEP250 PDE4DIP CCDC120 ARHGEF2 NEURL4 ODAD3 | 6.11e-05 | 318 | 136 | 10 | int:CEP170 |
| Interaction | MRPS5 interactions | 6.61e-05 | 321 | 136 | 10 | int:MRPS5 | |
| Interaction | AMOTL2 interactions | 7.51e-05 | 151 | 136 | 7 | int:AMOTL2 | |
| Interaction | YTHDC2 interactions | 7.74e-05 | 205 | 136 | 8 | int:YTHDC2 | |
| Interaction | TSPYL2 interactions | 7.87e-05 | 105 | 136 | 6 | int:TSPYL2 | |
| Interaction | NOL12 interactions | 8.16e-05 | 153 | 136 | 7 | int:NOL12 | |
| Interaction | ABCF2 interactions | 8.85e-05 | 209 | 136 | 8 | int:ABCF2 | |
| Interaction | SRBD1 interactions | 1.02e-04 | 110 | 136 | 6 | int:SRBD1 | |
| Interaction | MRPS10 interactions | 1.22e-04 | 219 | 136 | 8 | int:MRPS10 | |
| Interaction | PTCD3 interactions | 1.23e-04 | 346 | 136 | 10 | int:PTCD3 | |
| Interaction | SRRM1 interactions | 1.29e-04 | 348 | 136 | 10 | int:SRRM1 | |
| Interaction | RNLS interactions | 1.35e-04 | 3 | 136 | 2 | int:RNLS | |
| Interaction | CEP250 interactions | ATG16L1 LRCH2 HAUS5 CEP350 CEP250 CTNNB1 ARHGEF2 RPL4 NEURL4 | 1.47e-04 | 287 | 136 | 9 | int:CEP250 |
| Interaction | TUT7 interactions | 1.50e-04 | 118 | 136 | 6 | int:TUT7 | |
| Interaction | SRP9 interactions | MYC MYCN ATG16L1 ACTN2 TEFM RHOBTB1 ANAPC1 RHOBTB2 MAST1 CTNNB1 RPL4 | 1.54e-04 | 427 | 136 | 11 | int:SRP9 |
| Interaction | KXD1 interactions | 1.57e-04 | 170 | 136 | 7 | int:KXD1 | |
| Interaction | MRPS23 interactions | 1.85e-04 | 296 | 136 | 9 | int:MRPS23 | |
| Interaction | RPF2 interactions | 2.04e-04 | 236 | 136 | 8 | int:RPF2 | |
| Interaction | MRPS11 interactions | 2.10e-04 | 237 | 136 | 8 | int:MRPS11 | |
| Interaction | ATXN7L1 interactions | 2.21e-04 | 81 | 136 | 5 | int:ATXN7L1 | |
| Interaction | NEK2 interactions | 2.24e-04 | 127 | 136 | 6 | int:NEK2 | |
| Interaction | HSP90AB1 interactions | MYC MYCN ATG16L1 DET1 AICDA TSC1 TRIM6 GOLGA8Q MKS1 GLI1 RHOBTB2 CEP250 MAST1 MAP3K11 CTNNB1 SYVN1 RPL4 | 2.58e-04 | 960 | 136 | 17 | int:HSP90AB1 |
| Interaction | MRPS31 interactions | 2.61e-04 | 310 | 136 | 9 | int:MRPS31 | |
| Interaction | MRPL16 interactions | 2.82e-04 | 187 | 136 | 7 | int:MRPL16 | |
| Interaction | ZCCHC9 interactions | 2.92e-04 | 86 | 136 | 5 | int:ZCCHC9 | |
| Interaction | INIP interactions | 3.07e-04 | 48 | 136 | 4 | int:INIP | |
| Interaction | MRPS34 interactions | 3.07e-04 | 317 | 136 | 9 | int:MRPS34 | |
| Interaction | MRPS16 interactions | 3.21e-04 | 191 | 136 | 7 | int:MRPS16 | |
| Interaction | TPM3 interactions | MYC MYCN ACTN2 TLK1 RHOBTB1 RHOBTB2 RNF20 CTNNB1 ARHGEF2 RPL4 | 3.21e-04 | 390 | 136 | 10 | int:TPM3 |
| Interaction | SIPA1L2 interactions | 3.24e-04 | 136 | 136 | 6 | int:SIPA1L2 | |
| Interaction | GTPBP10 interactions | 3.24e-04 | 136 | 136 | 6 | int:GTPBP10 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q13 | 8.65e-05 | 454 | 141 | 8 | chr11q13 | |
| GeneFamily | Actinins | 8.82e-05 | 4 | 70 | 2 | 1112 | |
| GeneFamily | Ring finger proteins | 9.23e-05 | 275 | 70 | 7 | 58 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.21e-03 | 206 | 70 | 5 | 682 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.14e-03 | 66 | 70 | 3 | 722 | |
| GeneFamily | Rho family GTPases | 2.68e-03 | 20 | 70 | 2 | 390 | |
| GeneFamily | PDZ domain containing | 2.86e-03 | 152 | 70 | 4 | 1220 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.52e-03 | 161 | 70 | 4 | 593 | |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 ODAD3 BBOF1 | 8.33e-06 | 317 | 140 | 10 | M40298 |
| ToppCell | Ciliated_cells-B-Donor_08|World / lung cells shred on cell class, cell subclass, sample id | ERICH3 MARCHF10 CFAP73 HSPA12A CFAP54 KIF15 CCDC78 CFAP44 BBOF1 | 3.14e-09 | 166 | 141 | 9 | 4b1056aad8a99827835242b8ab0c7f2bb84471f1 |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | MARCHF10 CFAP73 DGCR6L CCDC78 CFAP45 CADPS2 UNC5D SMTNL2 BBOF1 | 3.49e-09 | 168 | 141 | 9 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 ODAD3 BBOF1 | 7.03e-09 | 182 | 141 | 9 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.28e-08 | 195 | 141 | 9 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.28e-08 | 195 | 141 | 9 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.34e-08 | 196 | 141 | 9 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.34e-08 | 196 | 141 | 9 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.40e-08 | 197 | 141 | 9 | 71fea4aa6ce96c7693fa94792d08770622873850 |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | FAM184A ERICH3 MARCHF10 CFAP73 HSPA12A CFAP54 CCDC78 CFAP74 CFAP44 | 1.40e-08 | 197 | 141 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.46e-08 | 198 | 141 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Ciliated|LPS_only / Treatment groups by lineage, cell group, cell type | ERICH3 MARCHF10 CFAP73 MKS1 CFAP54 CCDC78 CFAP45 CFAP44 BBOF1 | 1.46e-08 | 198 | 141 | 9 | 6d90b541fde357fbb40f8f7d4e8628a48b679718 |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | FAM184A ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP44 ODAD3 | 1.60e-08 | 200 | 141 | 9 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Ciliated|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 CFAP44 BBOF1 | 1.60e-08 | 200 | 141 | 9 | 6a2ccc71a0cbe04a542c379b28b5006de53981c3 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 ODAD3 BBOF1 | 1.60e-08 | 200 | 141 | 9 | 926a7ea94b5908aebf103893ea83ce9d25285b65 |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | ERICH3 MARCHF10 CFAP73 CFAP54 CCDC78 CFAP45 CFAP74 ODAD3 BBOF1 | 1.60e-08 | 200 | 141 | 9 | 06ce6e03498ba38ef6a06eaf2731e3b2eeda59eb |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.04e-07 | 178 | 141 | 8 | de5d50d7ca9ee9eb62f50c88a0c6d47f0694b2e6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 1.23e-07 | 182 | 141 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.34e-07 | 184 | 141 | 8 | 5daff849625f2f41d56615569c0ed59cd733b34c | |
| ToppCell | Ciliated_cells-B-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.39e-07 | 185 | 141 | 8 | 4fc7113d3dadc716ec5a8e62b58543cc00ce5b16 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 1.39e-07 | 185 | 141 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-07 | 186 | 141 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.45e-07 | 186 | 141 | 8 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.51e-07 | 187 | 141 | 8 | 2b4262c2e7c7830a976be168cee6eeb738d4feda | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 1.64e-07 | 189 | 141 | 8 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.64e-07 | 189 | 141 | 8 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | Ciliated_cells-B|World / lung cells shred on cell class, cell subclass, sample id | 1.71e-07 | 190 | 141 | 8 | 7031fbedc13be1a00f6333ad6d51849c3739c2e6 | |
| ToppCell | Epithelial_cells-Ciliated_cells-B|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.71e-07 | 190 | 141 | 8 | 426a4806f6e39d4d57c6746609d30bb3ca62df7d | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.85e-07 | 192 | 141 | 8 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 1.85e-07 | 192 | 141 | 8 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 1.85e-07 | 192 | 141 | 8 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.93e-07 | 193 | 141 | 8 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-07 | 194 | 141 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.01e-07 | 194 | 141 | 8 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.01e-07 | 194 | 141 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.09e-07 | 195 | 141 | 8 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-07 | 196 | 141 | 8 | 686a5a0ddb00929842c1c98445c59edfcc9a8a04 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.17e-07 | 196 | 141 | 8 | 67aefc480714e4b8c9ae53c036efdc07ec6f94af | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.17e-07 | 196 | 141 | 8 | ca56311edc6788e032e7635fa69b1e07035202b5 | |
| ToppCell | Severe_COVID-19-Epithelial-Ciliated|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.17e-07 | 196 | 141 | 8 | 1cdef976a754c90d18b6149d367bd64e6e99b0a9 | |
| ToppCell | BAL-Severe-Epithelial-Epithelial-Ciliated-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.17e-07 | 196 | 141 | 8 | 69f5081e06d84ec1d9695762df801a9d0df1984b | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.26e-07 | 197 | 141 | 8 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.26e-07 | 197 | 141 | 8 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.34e-07 | 198 | 141 | 8 | 16c54b884500066ade05a406915f9569ca8abdfc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Ciliated|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.44e-07 | 199 | 141 | 8 | b974b495cabbcc3934936cec846c0e2442a70ac3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-07 | 199 | 141 | 8 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.44e-07 | 199 | 141 | 8 | 15f7814b7074170eee7ccacaa670b1d128fc68bb | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.44e-07 | 199 | 141 | 8 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Ciliated|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.53e-07 | 200 | 141 | 8 | 9ae434c78e08adf95da49c85616e3ca72d1227bf | |
| ToppCell | Biopsy_Other_PF-Epithelial-Differentiating_Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.53e-07 | 200 | 141 | 8 | f7b4581d958afbd68f9045af619aaca0ab463439 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | 31d75c26055177d656df1fbb10b764cebd61e122 | |
| ToppCell | Biopsy_Other_PF-Epithelial-Ciliated|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.53e-07 | 200 | 141 | 8 | 721371698bce8890853fb6b6b01a2c20293b39e9 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | af6a551f83808c1c839df7ba7b1702ca28ea6e1b | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Ciliated|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | e1dce91c6c531bb212002a14705e496d77ad3490 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.53e-07 | 200 | 141 | 8 | 73ac1cf40ddd764be1100cbfaaa29563665457d8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-07 | 155 | 141 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.46e-07 | 155 | 141 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | 15-Distal-Epithelial-Multiciliated_cell|Distal / Age, Tissue, Lineage and Cell class | 1.15e-06 | 169 | 141 | 7 | 425d89ab69e9f9eb3df84056676423e390cc6ab1 | |
| ToppCell | Ciliated_cells-A-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.69e-06 | 179 | 141 | 7 | 0e6c22de2e3fb0ff23b3301863cf4011c5c59dff | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Pecam____fenestrated_capillary_endothelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.76e-06 | 180 | 141 | 7 | 79c5725f02e038d0187f4a1e1591f2492538aa57 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.82e-06 | 181 | 141 | 7 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Ciliated_cells-B-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-06 | 182 | 141 | 7 | e44c4810dc7d51a76b86d7623f8e4c4d8b4bf2fc | |
| ToppCell | Ciliated_cells-B-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.11e-06 | 185 | 141 | 7 | f012c243343e1d1956db19b34d062e9b13de2b2a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-06 | 185 | 141 | 7 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.11e-06 | 185 | 141 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Ciliated_cells-B-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-06 | 187 | 141 | 7 | 6fa38dbccca36bc7a4fef46de74c6688f599f421 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-06 | 187 | 141 | 7 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | 21-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 2.26e-06 | 187 | 141 | 7 | 1a2178a195d078d1963947b327c6d0d4f2f48341 | |
| ToppCell | Ciliated_cells-B-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 2.26e-06 | 187 | 141 | 7 | bc1f33f332ac939c2425f510173430ca2ba0c3ee | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.34e-06 | 188 | 141 | 7 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.34e-06 | 188 | 141 | 7 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.34e-06 | 188 | 141 | 7 | 2b6dfc88be9ded7b88da9fe78a9cd9f9b3af8af3 | |
| ToppCell | (7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.34e-06 | 188 | 141 | 7 | 5ba5cbb403518026e9040379fb5d99339ea977d8 | |
| ToppCell | COVID-19-lung-Ciliated|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.43e-06 | 189 | 141 | 7 | a2da5debd10f27b1280b40141ef0bfef007cc72c | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.43e-06 | 189 | 141 | 7 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Ciliated_1|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.43e-06 | 189 | 141 | 7 | dc440015949a768188c67661b6be63b1ead1a0f0 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 2.43e-06 | 189 | 141 | 7 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.43e-06 | 189 | 141 | 7 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Ciliated|World / shred by cell class for parenchyma | 2.43e-06 | 189 | 141 | 7 | 711181ca3b9102fb155168b646b0a9b09ff215b2 | |
| ToppCell | Epithelial_cells-Ciliated_cells-A|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 2.51e-06 | 190 | 141 | 7 | 549d813a8f23b175875e53347928941f143e236c | |
| ToppCell | Ciliated_cells-A|World / lung cells shred on cell class, cell subclass, sample id | 2.51e-06 | 190 | 141 | 7 | cd87731aaa7d252424f79cfce9f7931457f17bdf | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 191 | 141 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 191 | 141 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.60e-06 | 191 | 141 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.69e-06 | 192 | 141 | 7 | be592e661367affced9ebe80849b466e6adb3a34 | |
| ToppCell | 15-Trachea-Epithelial-Intermediate_ciliated|Trachea / Age, Tissue, Lineage and Cell class | 2.69e-06 | 192 | 141 | 7 | 9cbe961a800c981cdc742a47ed18e9c8eb6430bd | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.79e-06 | 193 | 141 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 2.79e-06 | 193 | 141 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | Bronchial_Biopsy-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.79e-06 | 193 | 141 | 7 | 0b62a6ddd7c42efd9f39781971d1438501e1fa8d | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.89e-06 | 194 | 141 | 7 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.89e-06 | 194 | 141 | 7 | 7a7ddccfe72a4a0dc4d1a5c809988f0069f9f1a3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.89e-06 | 194 | 141 | 7 | b0477583301dc6d9767b667bd2f8f94fbfaa6f81 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.89e-06 | 194 | 141 | 7 | a46238514bca920c3e3713d23c18ba24a09e2a29 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|COVID-19 / Condition, Lineage and Cell class | 2.89e-06 | 194 | 141 | 7 | 43be5fbd51dd58839cb03ca3ddd05a458e1ddb74 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 0e763f36786515698b593e5c93f6a56619c1242d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 581b04220587e1d5198b1abd6965965ace7803e7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 93b1559382a12cfb158aa5fac7386e38b4f87989 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.99e-06 | 195 | 141 | 7 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 3.09e-06 | 196 | 141 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| Drug | Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 1.51e-06 | 179 | 138 | 9 | 4404_DN | |
| Drug | Solasodine [126-17-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 3.18e-06 | 196 | 138 | 9 | 3830_DN | |
| Drug | Sulfinpyrazone [57-96-5]; Down 200; 9.8uM; HL60; HG-U133A | 3.75e-06 | 200 | 138 | 9 | 1574_DN | |
| Drug | Lanatoside C [17575-22-3]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.50e-05 | 181 | 138 | 8 | 6048_DN | |
| Drug | Strophantine octahydrate [11018-89-6]; Down 200; 5.4uM; PC3; HT_HG-U133A | 2.14e-05 | 190 | 138 | 8 | 6680_DN | |
| Drug | Digitoxigenin [143-62-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 2.22e-05 | 191 | 138 | 8 | 4217_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Down 200; 14.6uM; MCF7; HT_HG-U133A | 2.77e-05 | 197 | 138 | 8 | 2892_DN | |
| Drug | Bufexamac [2438-72-4]; Up 200; 18uM; MCF7; HT_HG-U133A | 2.87e-05 | 198 | 138 | 8 | 5515_UP | |
| Drug | 2-propylpentanoic acid; Down 200; 1000uM; HL60; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 6168_DN | |
| Drug | Ifosfamide [3778-73-2]; Down 200; 15.4uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 3485_DN | |
| Drug | genistein; Down 200; 10uM; MCF7; HT_HG-U133A | 2.98e-05 | 199 | 138 | 8 | 1660_DN | |
| Drug | Ascorbic acid [50-81-7]; Down 200; 22.4uM; HL60; HG-U133A | 3.08e-05 | 200 | 138 | 8 | 1610_DN | |
| Drug | NSC308848 | 3.65e-05 | 2 | 138 | 2 | CID000328773 | |
| Drug | B202 | 3.65e-05 | 2 | 138 | 2 | CID006435965 | |
| Disease | developmental and epileptic encephalopathy 64 (implicated_via_orthology) | 1.90e-05 | 2 | 129 | 2 | DOID:0070375 (implicated_via_orthology) | |
| Disease | Childhood Medulloblastoma | 3.77e-05 | 43 | 129 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.77e-05 | 43 | 129 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 3.77e-05 | 43 | 129 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.77e-05 | 43 | 129 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.77e-05 | 43 | 129 | 4 | C0278876 | |
| Disease | Warsaw breakage syndrome (implicated_via_orthology) | 5.67e-05 | 3 | 129 | 2 | DOID:0060535 (implicated_via_orthology) | |
| Disease | level of contactin-6 in blood serum | 5.67e-05 | 3 | 129 | 2 | OBA_2041074 | |
| Disease | Medulloblastoma | 6.87e-05 | 50 | 129 | 4 | C0025149 | |
| Disease | neural cell adhesion molecule l1-like protein measurement | 1.88e-04 | 5 | 129 | 2 | EFO_0020595 | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 1.88e-04 | 5 | 129 | 2 | DOID:0111128 (implicated_via_orthology) | |
| Disease | proline measurement, amino acid measurement | 1.88e-04 | 5 | 129 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | Bilateral Wilms Tumor | 2.74e-04 | 29 | 129 | 3 | C2930471 | |
| Disease | sexual dimorphism measurement | RASGRF1 ABT1 SIPA1 TRIP11 TP53INP2 SPTBN5 KCNH2 CEP250 ALPK3 MAP3K11 PLCB3 CTNNB1 ZNF367 IL27 | 3.54e-04 | 1106 | 129 | 14 | EFO_0021796 |
| Disease | contactin-4 measurement | 3.93e-04 | 7 | 129 | 2 | EFO_0020287 | |
| Disease | Nephroblastoma | 5.24e-04 | 36 | 129 | 3 | C0027708 | |
| Disease | Adult Hepatocellular Carcinoma | 6.69e-04 | 9 | 129 | 2 | C0279607 | |
| Disease | N-acetyl-isoputreanine measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0800107 | |
| Disease | Chromosome Breaks | 1.67e-03 | 14 | 129 | 2 | C0333704 | |
| Disease | thyroid gland papillary carcinoma (is_marker_for) | 1.67e-03 | 14 | 129 | 2 | DOID:3969 (is_marker_for) | |
| Disease | Chromosome Breakage | 1.67e-03 | 14 | 129 | 2 | C0376628 | |
| Disease | Muscular Atrophy | 1.92e-03 | 15 | 129 | 2 | C0026846 | |
| Disease | Neurogenic Muscular Atrophy | 1.92e-03 | 15 | 129 | 2 | C0270948 | |
| Disease | Hemangiosarcoma | 2.77e-03 | 18 | 129 | 2 | C0018923 | |
| Disease | Neoplastic Cell Transformation | 3.29e-03 | 139 | 129 | 4 | C0007621 | |
| Disease | hepatitis B (is_marker_for) | 3.77e-03 | 21 | 129 | 2 | DOID:2043 (is_marker_for) | |
| Disease | rheumatoid arthritis | 4.29e-03 | 462 | 129 | 7 | EFO_0000685 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRNLREQHSLQLQRR | 386 | Q8N715 | |
| REDQQRLHRNRKLVL | 171 | Q9Y5B0 | |
| NNTRIRRHLLRSGLI | 26 | Q5RHP9 | |
| RLQLAAVALQRHRAA | 2306 | Q96N23 | |
| QEELARQHANERLRR | 626 | P35609 | |
| ANQTLRRLHNRRTLS | 1366 | Q8WWN8 | |
| QRLNRHLAEVLERVN | 286 | Q5VTR2 | |
| LRNLEQISEQIHARR | 261 | Q7L8J4 | |
| HISEQLRRRDRLQRQ | 16 | Q676U5 | |
| LLQRQHALLQEELRR | 806 | Q92974 | |
| RQLNRHLTQLEQDKR | 1106 | Q6TFL3 | |
| SQSLEHRLRNRNLLL | 1371 | Q5H9F3 | |
| HENSVRLSRQLRRIL | 166 | Q9GZX7 | |
| RTSRRILERVENNHL | 1211 | Q96L96 | |
| LRLHREREQLLQARD | 96 | Q17RM4 | |
| GEHERRRHLRQNQRL | 811 | O94989 | |
| NERIHAQETIRRLQR | 1146 | Q96M86 | |
| ARQRTRRHLHDNVQL | 276 | P78325 | |
| QRLRLQNEHRVLRQA | 81 | Q14129 | |
| RRIQNQNVIHRLERR | 11 | Q7L5Y6 | |
| QNVIHRLERRRISSG | 16 | Q7L5Y6 | |
| TQLQELRREHARLQR | 121 | A6NFT4 | |
| RNTERIHQETLRRLE | 171 | Q8ND07 | |
| NHALRRLQERIHELQ | 1646 | Q96MT7 | |
| ILRIRSESNQQIRLH | 911 | Q8NB25 | |
| KRRQLEDERRQLQHL | 31 | O75781 | |
| TRHEQEQRRLERALA | 996 | Q6P2E9 | |
| ELQRVLEHRRRNQLI | 66 | O95990 | |
| NAQTDRVALRNLLRR | 91 | P30511 | |
| ADLRNLRALHLNSNR | 96 | Q96NI6 | |
| DLRVQDVRRLLQSAH | 1031 | Q9H1A4 | |
| ALQQTRRLLANARER | 226 | Q96SQ7 | |
| SEQQRILRRHQRERQ | 6 | Q7L8S5 | |
| ILRRHQRERQELQAQ | 11 | Q7L8S5 | |
| LVQLLVRAHQDTQRR | 536 | P35222 | |
| LELHQRREQLVERTR | 466 | Q96II8 | |
| LRVQQAALRAARLRH | 351 | Q9NZM5 | |
| ENHSLREENRRLRLL | 516 | Q9NS87 | |
| ENLHLSERQNRSVRL | 616 | O00533 | |
| RQQLLRHIEARRLDR | 1271 | Q96NW7 | |
| ERQRRLEPQLQHESR | 91 | P22083 | |
| ELRHQLQSRQQLRSR | 911 | Q9UBS5 | |
| RLDALQRQLNRLETR | 1041 | Q12809 | |
| EFRHLERLQQRQRQV | 461 | Q5VZ46 | |
| RRQVQADALRRLHEL | 146 | Q96HB5 | |
| RLQHANELRRQVREN | 471 | Q9UL16 | |
| HRNIREQQILTLFRE | 216 | Q53H82 | |
| RRLDVLQAIHTARQQ | 191 | Q7Z412 | |
| HISLLNRRQEERIRE | 331 | H3BV12 | |
| RRLENLRLDQLHQLR | 496 | P08151 | |
| QRHSIREINIRNERL | 131 | Q9Y4A0 | |
| EHIRRNRQSRTFLVE | 281 | O43301 | |
| RQHTQDTQRRALLLR | 116 | O94927 | |
| RRKQREERLQQLQHR | 136 | Q96FC9 | |
| RRNTILRQARNHKLR | 336 | P36578 | |
| PRATNDLVLRRARHQ | 876 | Q9Y2H9 | |
| RRLEHLRQALQRLRE | 1056 | Q01970 | |
| VRQLLRQREVTDHRL | 151 | Q8IYK2 | |
| LSEHLAFERQVRRQR | 156 | Q9ULW3 | |
| LARLQQLHRQELERC | 556 | Q96CN9 | |
| SRRIDRHLRSESQRQ | 16 | P19086 | |
| SLHVLEQRLRQRNTE | 126 | Q16774 | |
| LERRHRLQVLRQAEV | 396 | Q6ZNI0 | |
| RQRILSIDRNLRNQL | 151 | Q7L775 | |
| IRDVINVFHRLRQLR | 141 | Q96S94 | |
| RRTQLLHHTRRQLLE | 236 | P0CW27 | |
| LHHTRRQLLEQREQL | 241 | P0CW27 | |
| RLEIDRSRLQRHNVQ | 2281 | Q9BV73 | |
| RSRLQRHNVQLRSTL | 2286 | Q9BV73 | |
| RRKQREERLQQLQHR | 136 | A8MPP1 | |
| RLDLRDLQRHLRFQV | 141 | Q8NEV9 | |
| RLDVLHRHLQRNSER | 476 | Q5VT06 | |
| LFRILQRQTLDHRLN | 646 | Q86UW7 | |
| IRAAHRSREQQLARA | 281 | A2IDD5 | |
| QRLRLQNEHRVLRQA | 81 | Q9BY27 | |
| SNLIREVNRRLQLHL | 71 | Q96PX6 | |
| RLNHNQVERERLSRN | 766 | Q8NA82 | |
| LQLRIHRRNQEQISD | 21 | Q6ZN01 | |
| HISLLNRRQEERIRE | 331 | A6NCC3 | |
| QTHRERERNTQRLRD | 86 | Q5T7N8 | |
| RQRERGLQRQSSRHS | 856 | D6RIA3 | |
| RRELERSHRQLEQLE | 121 | Q8IVE0 | |
| RLQQRRERRALHQLK | 711 | Q14147 | |
| AFRHLVHQRRRQELE | 331 | Q9C0B2 | |
| QRSQAEQLRRREHLL | 431 | Q16584 | |
| NHSDRLRRNNAILRA | 486 | Q96JN8 | |
| SLRELNIRRNNLHVL | 226 | Q5VUJ6 | |
| HLREEREQIRQLRNN | 641 | Q5VUJ6 | |
| LQRDRQELRAASEHR | 206 | Q96A99 | |
| HRELQNTERQNRRIL | 371 | Q9HAU5 | |
| AQLRDRAHLSQQRRL | 71 | Q9BQI9 | |
| ERQHLEARLQSLRNI | 496 | Q86TM6 | |
| EERQQAELRRARTQH | 396 | Q3SY00 | |
| AELRRARTQHVQRQV | 401 | Q3SY00 | |
| RLRHLRNIAARNIVN | 41 | Q9P2Y5 | |
| LQREINHNRALLRND | 521 | Q8NBJ9 | |
| AQLISALRQHRRNDV | 476 | O75509 | |
| LHRHARQSLQALRRE | 226 | Q6T4R5 | |
| RRTHNVLERQRRNEL | 356 | P01106 | |
| ARNASLERARHQLQL | 1421 | Q9Y2K3 | |
| ALRHQVVLRQRRLEE | 166 | A5D8V7 | |
| VVLRQRRLEELQLQH | 171 | A5D8V7 | |
| RHDIRNQLRRNLTLT | 166 | Q9NYQ3 | |
| AQLREVHLRRFNLRR | 1971 | Q6ZNJ1 | |
| DNAIRAALISRRHLQ | 201 | Q9BYZ6 | |
| ALEEEVRSLRHNNRR | 1001 | Q96FS4 | |
| VRSLRHNNRRLQAES | 1006 | Q96FS4 | |
| ERRLRAHNRNLLSID | 1786 | Q9UKZ4 | |
| AQEARRVRHLHARLQ | 436 | Q9BR26 | |
| LRGRRSINIVEHREN | 91 | Q96QE5 | |
| DNAIRAALISRRHLQ | 201 | O94844 | |
| AIRVSARHLRRLQQR | 446 | Q9NZ20 | |
| ARHLRRLQQRRHQLQ | 451 | Q9NZ20 | |
| IRRAATNRVLNVLRH | 946 | Q13972 | |
| IPVNEENRRSLNRRH | 96 | O75570 | |
| RLHLQRLVSNESQRR | 356 | Q5JPH6 | |
| AGTRRHRLEELRQLQ | 2671 | Q9NRC6 | |
| SVRTLQQQHRRLERE | 3246 | Q9NRC6 | |
| PAQLQELEHRVARRR | 41 | Q7Z7C7 | |
| RAHRLAELQEQLRAV | 516 | P25440 | |
| RRLQRLQHLAEKFRQ | 401 | Q08043 | |
| NPVHARERLRNIERI | 46 | Q8TBE1 | |
| NRDPQLNERVHRVRA | 611 | Q969H4 | |
| ARRHQLQEASRNRDR | 1261 | O75153 | |
| LALRERRINNLDNSH | 1101 | Q9BXT8 | |
| LRRLLQEQHQLSSRR | 4646 | Q63HN8 | |
| NLQLADGRRHRILLR | 116 | P35443 | |
| DGRRHRILLRLSNLQ | 121 | P35443 | |
| RVRNLHIRELKRINN | 426 | Q9UKI8 | |
| RFKRQQHALRNRRLL | 706 | Q92574 | |
| VRNLRLRVHLQRITS | 21 | Q9NXB0 | |
| HNILERQRRNDLRSS | 386 | P04198 | |
| RLQRARQRAERHALS | 171 | Q8IXH6 | |
| QQRRLLGRHEQVVER | 26 | Q8NBT2 | |
| RTLHLERLQRVRSAQ | 831 | P38935 | |
| AITQVHRQGERRREL | 286 | Q2TAL5 | |
| LERRRRTLLQQLDDH | 856 | Q6NWY9 | |
| IRRNRQLERLASHIK | 151 | O75678 | |
| RADHNLIIRQARLSD | 211 | Q6UXZ4 | |
| RRLDDHQTVRDARLQ | 61 | A0A2R8Y7D0 | |
| SSARRDEHRLRQQQR | 856 | Q6PKC3 | |
| RRFRQRTALVIHQRI | 296 | Q96CS4 | |
| RSNQELERLRNHLLE | 1576 | Q15643 | |
| QRRLQEQRERLHGAL | 321 | Q7RTV3 | |
| AKEQRRQQRLRLHTS | 1186 | Q8IWV8 | |
| QLRRQEREQQLRHDR | 1651 | Q07283 | |
| ERRFRDQLTLRLHQR | 166 | Q7Z7K2 | |
| NRHLANIVRRLREVV | 71 | Q9C030 | |
| QIELHNSIRDRQGRR | 91 | Q96EY4 | |
| EQREHELNRRRQLGL | 461 | Q9P2D8 | |
| RQLAKRQHLEEQRLQ | 86 | Q9Y247 | |
| RQHLEEQRLQQERQR | 91 | Q9Y247 | |
| HISLLNRRQEERIRE | 331 | F8WBI6 | |
| VLREDNRRLQAQLSH | 1906 | Q5VU43 |